UB
IMVT icon

UMB Bank’s Immunovant IMVT Stock Holding History

UMB Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-141
Closed -$1K – 2021
2021
Q4 		$1K Buy
+141
New +$1.16K ﹤0.01% 1920

Other funds holding IMVT

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

UMB Bank's IMVT Position: Q1 2022 in Review

UMB Bank sold out of Immunovant (IMVT) in Q1 2022, closing a stake of 141 shares — an estimated $1K sold.

UMB Bank first reported a position in IMVT in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 112 funds tracked by Wall St. Rank hold IMVT as of Q1 2022.

  • UMB Bank reported no remaining Immunovant position as of Q1 2022 after selling out during the quarter.
  • UMB Bank sold 141 Immunovant shares in Q1 2022, an estimated $1K.
  • UMB Bank first reported a position in Immunovant in Q4 2021 and held it in 1 quarter.
  • UMB Bank's Immunovant position peaked at $1K in Q4 2021.
  • 112 funds tracked by Wall St. Rank held Immunovant as of Q1 2022.

Based on UMB Bank's 13F filing for Q1 2022, filed 22 Apr 2022.